Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:18
Private Equity Firms Have $1.5 Trillion to Spend, But Are Struggling to Seal Deals
Private equity firms hunting for acquisitions with their $1.5 trillion of unspent capital are struggling to seal deals
2023-06-13 17:57